期刊文献+

基于microRNA调控网络预测卵巢癌多药耐药相关基因 被引量:2

MicroRNA regulatory network-based prediction of multidrug resistance genes in ovarian cancer
下载PDF
导出
摘要 目的:基于microRNA(miRNA)调控网络预测卵巢癌多药耐药相关基因。方法:综合运用文本挖掘、网络构建和预测等生物信息学分析方法,挖掘卵巢癌化疗耐药相关miRNA和miRNA-靶基因数据,并构建miRNA调控网络,利用已知miRNA对卵巢癌多药耐药相关基因进行预测。结果:文本挖掘出11个与卵巢癌化疗耐药相关的miRNA,包括miR-130a、miR-214、let-7i、miR-125b、miR-376c、miR-199a、miR-93、miR-141、miR-130b、miR-193b*和miR-200c。在miRNA靶基因预测数据软件Target Scan中挖掘出47 077个miRNA-靶基因数据,而Pic Tar挖掘出1 675个miRNA-靶基因数据。在miRNA调控网络中,神经素1基因(neuropilins,NRP1)是最重要的Hub-基因。结论:利用已知miRNA构建miRNA调控网络进而预测卵巢癌多药耐药相关基因是一种行之有效的方法。NRP1极有可能在卵巢癌化疗耐药形成中扮演着重要的角色,是卵巢癌潜在的药物治疗靶点。 Objective: To predict genes related to multidrug resistance( MDR) in ovarian cancer based on the microRNA( miRNA) regulatory network. Methods: To identify potential genes associated with multidrug resistance in ovarian cancer based on published miRNAs and miRNA-target genes were identified using a comprehensive bioinformatics approaches including text mining and network researching. Results: Eleven miRNAs related to ovarian cancer chemoresistance were identified,including miR-130 a,miR-214,let-7i,miR-125 b,miR-376 c,miR-199 a,miR-93,miR-141,miR-130 b,miR-193b*and miR-200 c. A total of 47 077 putative targets were predicted using the Target Scan algorithm and 1 675 other targets were predicted using the Pic Tar algorithm. Neuropilins( NRP1) was the most important Hub-gene found in the cancer miRNA regulatory network. Conclusion: It is an effective method to construct a miRNA regulatory network to predict genes related to MDR in ovarian cancer by utilizing the existing information on miRNAs. Using this approach,we predict that NRP1 may play an important role in ovarian cancer chemoresistance and would be a potential therapeutic target for ovarian cancer.
出处 《中国肿瘤生物治疗杂志》 CAS CSCD 北大核心 2015年第2期204-208,共5页 Chinese Journal of Cancer Biotherapy
基金 国家高技术研究发展计划(863计划)资助项目(No.2012AA02A507) 广西自然科学基金资助项目(桂财教2014-118号) 广西科学研究与技术开发计划课题资助项目(桂科攻14124004-1-24)~~
关键词 卵巢癌 多药耐药 基因 microRNA调控网络 预测 神经素1基因 ovarian cancer multidrug resistance gene microRNA regulatory network predict neuropilins 1(NRP1)
  • 相关文献

参考文献32

  • 1Jemal Ahmedin,Siegel Rebecca,Xu Jiaquan,Ward Elizabeth.Cancer statistics, 2010. CA: a cancer journal for clinicians . 2010
  • 2Prislei Silvia,Martinelli Enrica,Mariani Marisa,Raspaglio Giuseppina,Sieber Steven,Ferrandina Gabriella,Shahabi Shohreh,Scambia Giovanni,Ferlini Cristiano.MiR-200c and HuR in ovarian cancer. BMC Cancer . 2013
  • 3Calin George A,Croce Carlo M.MicroRNA signatures in human cancers. Nature reviews. Cancer . 2006
  • 4He L,Hannon GJ.MicroRNAs: small RNAs with a big role in gene regulation. Nature Reviews Genetics . 2004
  • 5Ro Seungil,Park Chanjae,Young David,Sanders Kenton M,Yan Wei.Tissue-dependent paired expression of miRNAs. Nucleic Acids Research . 2007
  • 6侯晋,曹雪涛.MicroRNA与肝癌诊治:新的机遇和挑战[J].中国肿瘤生物治疗杂志,2015,22(1):1-7. 被引量:10
  • 7Calin GA,Dumitru CD,Shimizu M,et al.Frequent deletions and down-regulation of micro-RNA genes miR15 and miR16 at 13q14 in chronic lymphocytic leukemia. Proceedings of the National Academy of Sciences of the United States of America . 2002
  • 8Amelia Cimmino,George Adrian Calin,Muller Fabbri,Marilena V. Iorio,Manuela Ferracin,Masayoshi Shimizu,Sylwia E. Wojcik,Rami I. Aqeilan,Simona Zupo,Mariella Dono,Laura Rassenti,Hansjuerg Alder,Stefano Volinia,Chang-gong Liu,Thomas J. Kipps,M.miR-15 and miR-16 induce apoptosis by targeting BCL2. Proceedings of the National Academy of Sciences of the United States of America . 2005
  • 9Hua Yang,William Kong,Lili He,Jian-Jun Zhao,Joshua D. O’Donnell,Jiawang Wang,Robert M. Wenham,Domenico Coppola,Patricia A. Kruk,Santo V. Nicosia,Jin Q. Che.MicroRNA Expression Profiling in Human Ovarian Cancer: miR-214 Induces Cell Survival and Cisplatin Resistance by Targeting PTEN. Cancer Research . 2008
  • 10Krek Azra,Grün Dominic,Poy Matthew N,Wolf Rachel,Rosenberg Lauren,Epstein Eric J,MacMenamin Philip,da Piedade Isabelle,Gunsalus Kristin C,Stoffel Markus,Rajewsky Nikolaus.Combinatorial microRNA target predictions. Nature Genetics . 2005

二级参考文献28

  • 1Hassan El-Garem,Ayman Ammer,Hany Shehab,Olfat Shaker,Mohammed Anwer,Wafaa El-Akel,Heba Omar.Circulating micro RNA, mi R-122 and mi R-221 signature in Egyptian patients with chronic hepatitis C related hepatocellular carcinoma[J].World Journal of Hepatology,2014,6(11):818-824. 被引量:18
  • 2Sorrentino A,Liu CG,Addario A,et al.Role of mi- croRNAs in drug-resistant ovarian cancer cells. Gynecologic Oncology . 2008
  • 3van Jaarsveld MT,Helleman J,Berns EM,et al.Mi- croRNAs in ovarian cancer biology and therapy resis- tance. International Journal of Biochemistry Cell Biology The . 2010
  • 4Ma J,Dong C,Ji C.MicroRNA and drug resistance. Cancer Gene Therapy . 2010
  • 5Jones NA,Turner J,McIlwrath AJ,et al.Cisplatin- and paclitaxel-induced apoptosis of ovarian carcinoma cells and the relationship between bax and bak up-regulation and the functional status of p53. Molecular Pharmacology . 1998
  • 6Legge F,Ferrandina G,Salutari V,et al.Biological char- acterization of ovarian cancer: prognostic and therapeutic implications. Annals of Oncology . 2005
  • 7Reed NS,Sadozye AH.Role of chemotherapy in the management of epithelial ovarian cancer. Expert Review of Anticancer Therapy . 2005
  • 8Ferrandina,G.et al.Class Ⅲ beta-tubulin overexpression is a marker of poor clinical outcome in advanced ovarian cancer patients. Clinical Cancer Research . 2006
  • 9Zheng T,Wang J,Chen X,Liu L.Role of microRNA in anticancer drug resistance. International Journal of Cancer . 2010
  • 10Yang H,Kong W,He L, etal.MicroRNA expression profiling in human ovarian cancer: miR-214 induces cell survival and cisplatin resistance by targeting PTEN. Cancer Research . 2008

共引文献54

同被引文献23

引证文献2

二级引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部